We are pleased to announce that ModiQuest Research has acquired ’Crédit d’Impôt Recherche’ (CIR) accreditation from the French Ministry of Higher Education and Research. The French R&D tax credit initiative gives eligible research-based French companies, who are subject to corporate tax in France, the ability to claim significant tax reduction on costs generated in R&D activities outsourced to ModiQuest Research.
For over 10 years ModiQuest Research specializes in the generation of monoclonal antibodies against difficult target antigens for R&D, diagnostic and therapeutic applications. Using our proprietary ModiVaccTM (cell immunisation) ModiFuseTM (electrofusion hybridoma), ModiSelectTM (B-cell selection) and ModiPhageTM (phage display) technologies, we can generate monoclonal antibodies from various backgrounds such as mouse, rat, rabbit, chicken, llama and human against virtually any target. Besides lead antibody generation, we also provide antibody development and optimization (ModiTuneTM), such as affinity maturation, humanization and production (ModiXpressTM) in transient and stable mammalian cell systems. All services are offered on a fee-for-service basis.